The SHARE Communication Framework for mCRPC: video, slides and e-learning

MEET THE EXPERTS ALL PROGRAMMES DEVELOPED COLLABORATIONS CONTACT

The SHARE Communication Framework for mCRPC: video, slides and e-learning

Assoc. Prof. Alicia Morgans, Prof. David Pfister, Assoc. Prof. Tanya Dorff

SHARE provides a simple 5-step approach aimed at improving outcomes through engaging patients with metastatic castration resistant prostate cancer (mCRPC) in their own treatment decisions.

Assoc. Prof. Alicia Morgans

Medical Oncologist

Dana-Farber Cancer Institute

United States (US)

Prof. David Pfister

Urologist

University Hospital of Cologne

Germany

Assoc. Prof. Tanya Dorff

Medical Oncologist

City of Hope Comprehensive Cancer Center

United States (US)

Biography Disclosures

Prof. David Pfister

Urologist

University Hospital of Cologne

Germany

After finishing medical school in November 2004 Dr Pfister started his residency in the Department of Urology at the University of Cologne. For his endoscopic training, he switched to the General Hospital in Weiden (Oberpfalz/Bavaria) between August 2006 and March 2007. After returning to Cologne Dr Pfister heightened my oncologic education under Prof. Heidenreich. The oncologic training consisted of two arms: medical and surgical oncology. In 2009 his education was augmented at the University Hospital of Aachen. In 2010 he passed his urologic board exam. Since 2011 Dr Pfister has been working as a staff urologist with main interests in castration-resistant prostate cancer and testicular cancer. In 2011 he passed the Charles Huggins grant, an educational grant at the Center for Prostate Disease Research in Maryland, USA. In 2012 Dr Pfister received an additional qualification in the systemic treatment of solid tumours and since that time he has organised and led the urological clinical trial centre. In 2012 Dr Pfister qualified as a Professor and became an Associate Professor in November 2012 for medical oncologic treatment in urological tumours. At the end of 2015 he became the Commissionary Leader of the Urologic Department of the University of Aachen. Since 2016 Dr Pfister has become the Deputy Director of the Department of Urology, Uro-oncology and Robot-Assisted Surgery, University Hospital of Cologne. Special interest is castration-resistant, radiation-resistant prostate cancer and testicular cancer.

Prof. David Pfister has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Bayer, Merck, MSD, Janssen and Pfizer.

Biography Disclosures

Assoc. Prof. Tanya Dorff

Medical Oncologist

City of Hope Comprehensive Cancer Center

United States (US)

Following a residency at Mt. Sinai Hospital in New York City, Dr Dorff came to LAC + USC Medical Center for her hematology and medical oncology fellowship. She currently heads the Genitourinary group within the Department of Medical Oncology at the City of Hope Comprehensive Cancer Center. In addition to being a devoted clinician and translational researcher, Dr Dorff has authored more than 45 peer reviewed articles as well as 35 review articles/commentaries. Dr Dorff serves as an associate editor for Clinical Genitourinary Cancer and Seminars in Urologic Oncology. She has lectured on prostate and bladder cancer treatment nationally and internationally and has presented her research at national meetings. Current research interests include the effects of fasting on chemotherapy side effects and cancer control and immunotherapy for prostate cancer. She has been the principal investigator for more than a dozen clinical trials, involving targeted therapy and immunotherapy, for genitourinary cancers.

Assoc. Prof. Tanya Dorff has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

AstraZeneca, Astellas, Exelixis, Janssen and SeaGen.

time E-learning | open 60 min |accreditation: EACCME | Sep 2019

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

download resources

DIOWNLOAD SLIDES - PDF

This programme was made for you: your opinion matters

Share your feedback in just 4 clicks and help us to continue to create the content you need.

I agree that this educational programme:

GU CONNECT has developed an accredited interactive e-learning, slide set and short informative videos to help you confidently and quickly apply the SHARE Communication Framework and move towards even better patient conversations.

Supported by:

This course has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) and ECMEC® is available. Through an agreement between the European Union of Medical Specialists (UEMS) and the American Medical Association (AMA), physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™.

GU CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca, Bayer and Eisai Europe Limited.

Other programmes of interest

Prof. Dimitrios Tsakiris

Dr Lars Asmis

Podcast

2 min

Cancer and Thrombosis

Sep 2023

Dr Elisa Agostinetto

Prof. Valentina Guarneri

Interactive patient case

15 min

Oral SERDs: New Endocrine Therapy Options in ER+ Advanced or Meta...

Sep 2023

Prof. Chee-Kiat Tan

Publication

5 min

Surveillance and Diagnosis of HCC in Asia: Poster Presentation at...

Sep 2023

Assoc. Prof. Gerald Prager

Video

4 min

Long-term Response in Advanced Colorectal Cancer

Sep 2023

Prof. Dr Jeroen Dekervel

Dr Amit Singal

Podcast

29 min

A New Era in Treating Patients with Advanced HCC

Sep 2023

Dr Jaume Capdevila

Asst. Prof. Mauro Cives

Micro learning

30 min

Accreditation: EACCME

Recognising, Diagnosing and Managing Neuroendocrine Tumours

Aug 2023

Acromegaly and Neuroendocrine Tumours Global Survey

Publication

15 min

Acromegaly and Neuroendocrine Tumours Global Survey

Aug 2023

Prof. Shaheenah Dawood

Assoc. Clinical Professor Rena Callahan

Podcast

74 min

Oral SERDs in ER+ Breast Cancer

Aug 2023

Dr Tracy L Stockley

Prof. David Hong

Podcast

24 min

An Introduction to Molecular Testing

Jul 2023

Dr Neal Shore

Dr Andrew J. Armstrong

Video

10 min

Clinical Implementation of Testing and PARPi as Monotherapy or in...

Aug 2023

Janet Forgenie

Video

3 min

Nursing Support for mCRPC Patients During Radiopharmaceutical Tre...

Jul 2023

Prof. Andrea Sartore-Bianchi

Video

5 min

Conference Update: ASCO and WCGIC 2023

Jul 2023

Other programmes developed by Assoc. Prof. Alicia Morgans

Assoc. Prof. Alicia Morgans

Medical Oncologist

Dana-Farber Cancer Institute

United States (US)

Assoc. Prof. Alicia Morgans

Dr Pasquale Rescigno

Micro learning

8 min

Accreditation: EACCME

PARP inhibitors in prostate cancer and the rationale behind combi...

Jan 2023

Brenda Martone

Assoc. Prof. Alicia Morgans

Podcast

24 min

Podcast: Shared decision-making in nmCRPC - Treatment considerati...

Jul 2022

Assoc. Prof. Alicia Morgans

Dr Neal D. Shore

Podcast

40 min

Prostate Cancer Highlights from ASCO GU 2022

Mar 2022

Assoc. Prof. Alicia Morgans

Dr Jason Alcorn

Podcast

27 min

Accreditation: EACCME

PARP inhibitors in prostate cancer: Management of adverse events ...

Jan 2022

Assoc. Prof. Alicia Morgans

5 min

Integrating patient preference into treatment decisions for advan...

Dec 2021

Assoc. Prof. Alicia Morgans

5 min

GU CONNECT update from Orlando (1/3)

2017

Assoc. Prof. Alicia Morgans

5 min

Advances in metastatic hormone-sensitive prostate cancer

2018

Assoc. Prof. Alicia Morgans

Prof. Gerhardt Attard

E-learning

5 min

E-Learning: Treatment sequencing for mCRPC patients within the ch...

2019

Dr Neal D. Shore

Assoc. Prof. Alicia Morgans

Webinar

35 min

Prostate Cancer Management Masterclass: mCSPC Plenary Session 1

Dec 2020

Dr Neal D. Shore

Assoc. Prof. Alicia Morgans

Assoc. Prof. Tanya Dorff

And others...

5 min

Prostate Cancer Management Masterclass: An Introduction

Dec 2020

Prof. David Pfister

Assoc. Prof. Alicia Morgans

60 min

Accreditation: EACCME

Experts Knowledge Share: Managing nmCRPC and new imaging modaliti...

Feb 2021

Other programmes developed by Prof. David Pfister

Prof. David Pfister

Urologist

University Hospital of Cologne

Germany

Prof. David Pfister

5 min

Highlights of 2021 in GU Oncology

Dec 2021

Prof. Sandy Srinivas

Prof. David Pfister

5 min

Immunotherapy in genitourinary tumors

Mar 2017

Prof. David Pfister

5 min

Update from ASCO GU 2018 (3/3)

Jun 2018

Prof. David Pfister

5 min

New therapies for metastatic hormone sensitive prostate cancer

2019

Prof. David Pfister

Assoc. Prof. Alicia Morgans

60 min

Accreditation: EACCME

Experts Knowledge Share: Managing nmCRPC and new imaging modaliti...

Feb 2021

Other programmes developed by Assoc. Prof. Tanya Dorff

Assoc. Prof. Tanya Dorff

Medical Oncologist

City of Hope Comprehensive Cancer Center

United States (US)

Dr Neal Shore

Dr Elena Castro

Prof. Neeraj Agarwal

And others...

Podcast

64 min

Podcast: PARP inhibitors alone or in combination with novel hormo...

Mar 2023

Prof. Fred Saad

Assoc. Prof. Tanya Dorff

Prof. Gerhardt Attard

And others...

78 min

Accreditation: EACCME

Experts Knowledge Share: Incorporating PARP inhibitors into prost...

Dec 2022

Assoc. Prof. Tanya Dorff

Dr Neal Shore

Podcast

22 min

Podcast: Timing of ARSI and taxanes for mCSPC

Jul 2022

Image of Fred Saad, Tanya Dorff and Gerhardt Attard

Prof. Gerhardt Attard

Assoc. Prof. Tanya Dorff

Prof. Fred Saad

60 min

Accreditation: EACCME

Targeting Advanced Prostate Cancer with PARP inhibitors: Who, Whe...

Mar 2022

Dr Phillip Koo

Assoc. Prof. Tanya Dorff

Podcast

22 min

Accreditation: EACCME

Radiopharmaceuticals in prostate cancer - PSMA Theranostics (Epis...

May 2021

Image of Drs. Tanya Dorff, Phillip Koo and Neal Shore

Dr Neal D. Shore

Assoc. Prof. Tanya Dorff

Dr Phillip Koo

Podcast

30 min

Accreditation: EACCME

Radiopharmaceuticals in prostate cancer - radium-223 (Episode 1 o...

May 2021

Assoc. Prof. Tanya Dorff

5 min

GU CONNECT Prostate Cancer Update from ESMO 2016 (1/3)

Sep 2016

Assoc. Prof. Tanya Dorff

Video

5 min

A CONNECT Update from ASCO GU 2018 (1 of 3)

2017

Assoc. Prof. Tanya Dorff

5 min

Treating Oligometastatic Prostate Cancer

2019

Prof. Evan Yu

Assoc. Prof. Tanya Dorff

Webinar

60 min

Prostate Cancer Management Masterclass: CRPC Plenary Session 2

Dec 2020

Dr Neal D. Shore

Assoc. Prof. Alicia Morgans

Assoc. Prof. Tanya Dorff

And others...

5 min

Prostate Cancer Management Masterclass: An Introduction

Dec 2020

Cookie	Duration	Description
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.